Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed

References

• CammAJKirchhofPLipGYEuropean Heart Rhythm AssociationEuropean Association for Cardio-Thoracic SurgeryGuidelines for the management of atrial fibrillation The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Eur Heart J201031192369242920802247
   PubMed Web of Science ®Google Scholar
• CammAJLipGYDe CaterinaR2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation: An Update of the 2010 ESC Guidelines for the Management of Atrial FibrillationRevista Española de Cardiología (English Edition)201366154
   Web of Science ®Google Scholar
• JanuaryCWannLAlpertJACC/AHA Task Force MembersAHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm SocietyCirculation2014130232071210424682348
   PubMed Web of Science ®Google Scholar
• PetersNSSchillingRJKanagaratnamPMarkidesVAtrial fibrillation: strategies to control, combat, and cureLancet2002359930659360311867130
   PubMed Web of Science ®Google Scholar
• LipGYTseHFManagement of atrial fibrillationLancet2007370958760461817707756
   PubMed Web of Science ®Google Scholar
• Carl van WalravenMHartRGConnollySEffect of age on stroke prevention therapy in patients with atrial fibrillationStroke20094041410141619182090
   PubMed Web of Science ®Google Scholar
• HughesMLipGGuideline Development Group. National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical ExcellenceStroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness dataThromb Haemost200899229530418278178
   PubMed Web of Science ®Google Scholar
• Investigators58 AF. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1,066 patients from 3 clinical trialsArch Intern Med19981581213169645825
   PubMedGoogle Scholar
• BanerjeeATaillandierSOlesenJBEjection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation ProjectEur J Heart Fail201214329530122294759
   PubMed Web of Science ®Google Scholar
• GoASMozaffarianDRogerVLAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2014 update: a report from the American Heart AssociationCirculation2014129339941024446411
   PubMed Web of Science ®Google Scholar
• MiyasakaYBarnesMEGershBJSecular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalenceCirculation2006114211912516818816
   PubMed Web of Science ®Google Scholar
• GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationJAMA2001285222864287011401607
   PubMed Web of Science ®Google Scholar
• LipGYNieuwlaatRPistersRLaneDACrijnsHJRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillationChest2010137226327219762550
   PubMed Web of Science ®Google Scholar
• BrownTMSiuKWalkerDPladevall-VilaMSanderSMordinMDevelopment of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillationJ Manag Care Pharm201218535136222663168
   PubMedGoogle Scholar
• GuptaSGorenAFreedmanDRisk of stroke and preventative steps among patients diagnosed with atrial fibrillation in EuropeISPOR 13th Annual European CongressNovember 6th–9th, 2010Prague, Czech Republic
   Google Scholar
• PatelAALennertBMacomsonBAnticoagulant use for prevention of stroke in a commercial population with atrial fibrillationAm Health Drug Benefits20125529129824991327
   PubMedGoogle Scholar
• LangKBozkayaDPatelAAAnticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysisBMC Health Serv Res201414132925069459
   PubMed Web of Science ®Google Scholar
• FangMCGoASChangYA new risk scheme to predict warfarin-associated hemorrhage. The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyJ Am Coll Cardiol201158439540121757117
   PubMed Web of Science ®Google Scholar
• NaccarelliGVVarkerHLinJSchulmanKLIncreasing Prevalence of atrial fibrillation and flutter in the United StatesAm J Cardiol2009104111534153919932788
   PubMed Web of Science ®Google Scholar
• SemchukWMLevacBLaraMShakespeareAEversTBoltJManagement of stroke prevention in Canadian patients with atrial fibrillation at moderate to high risk of strokeCan J Hosp Pharm201366529624159232
   PubMedGoogle Scholar
• PatronoCAndreottiFAntithrombotic therapy for patients with atrial fibrillation and atherothrombotic vascular disease: striking the right balance between efficacy and safetyCirculation2013128768468623861513
   PubMed Web of Science ®Google Scholar
• HeidbuchelHVerhammePAlingsMEuropean Heart Rhythm AssociationEuropean Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillationEuropace201315562565123625942
   PubMed Web of Science ®Google Scholar
• JoverERoldánVGallegoPPredictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulationRevista Española de Cardiología (English Edition)2012657627633
   Web of Science ®Google Scholar